Ensuring Reproducibly Accurate Drug Dilution Protocols

摘要

Respiratory drug discovery and development specialists, Pulmocide Ltd, are using an Integra VIAFLO Assist pipetting assistant to enhance the productivity and reproducibility of their screening of novel compounds in a range of biological assays. Pulmocide is generating a pipeline of potent anti-infective agents for delivery by inhaled administration for the treatment of life threatening lower respiratory tract viral and fungal infections specifically RSV pneumonia and Invasive Aspergillosis. The lung is the principle site of infection for RSV and Aspergillus and delivery of highly effective new treatments directly to the lung will allow rapid control of infection with minimal systemic toxicity. Lauren Anderson Dring, Research Scientist and Project Manager at Pulmocide commented: "Our work involves medium throughput screening of novel compounds in a range of biological assays. This involves accurate drug dilutions which ultimately allow us to analysis each compound's potency; thus aiding the rapid discovery of highly effective new treatments for respiratory tract infections.